(Abst.) Risk of infection in PwMS treated w/DMT: A Delphi consensus statement on: September 22, 2020, 08:04:07 pm #1 From Multiple Sclerosis Journal (September 17, 2020), "The risk of infections in patients with multiple sclerosis treated with disease-modifying therapies: A Delphi consensus statement":https://journals.sagepub.com/doi/abs/10.1177/1352458520952311Delphi method: Delphi method - Wikipedia en.wikipedia.org We don't really find out from the abstract just what was concluded but nonetheless this abstract does show that infections in MS are a continuing concern, in relation to the disease-modifying therapies. Last Edit: September 22, 2020, 08:06:32 pm by agate Logged MS Speaks--online for 20 yearsSPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) 12/16/20 - 3/16/24.
